Treatment of metastatic transitional cell carcinoma following renal transplantation.

Renal transplantation was performed in a patient with a history of surgical excision for localized transitional cell carcinoma. The graft functioned well; however, metastatic transitional cell carcinoma developed following transplantation. The patient was treated sequentially with CISCA (cisplatin, Cytoxan [cyclophosphamide], and Adriamycin [doxorubicin hydrochloride]) and M-VAC (methotrexate, vinblastine, Adriamycin, and cisplatin) with no alteration in maintenance immunosuppression. Full-dose chemotherapy was well tolerated, with no impairment of renal function, and a demonstrable reduction in tumor burden was achieved. The patient ultimately died of metastatic disease but enjoyed an excellent quality of life throughout the post-transplant period.

[1]  W. Clark,et al.  CARDIAC TRANSPLANTATION IN PATIENTS WITH PREEXISTING MALIGNANCIES , 1991, Transplantation.

[2]  M. First,et al.  Development and incidence of cancer following cyclosporine therapy. , 1986, Transplantation proceedings.

[3]  D. V. van Thiel,et al.  Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. , 1986, Surgery, gynecology & obstetrics.

[4]  T. Starzl,et al.  Role of Liver Transplantation in Cancer Therapy , 1985, Annals of surgery.

[5]  N. Geller,et al.  Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. , 1985, The Journal of urology.

[6]  I. Penn.  TRANSPLANTATION IN PATIENTS WITH PRIMARY RENAL MALIGNANCIES , 1977, Transplantation.

[7]  I. Penn.  Development of cancer as a complication of clinical transplantation. , 1977, Transplantation proceedings.

[8]  R. Calne,et al.  Renal Transplantation in Patients with Carcinoma , 1974, British medical journal.

[9]  C. Kjellstrand,et al.  Long-term results of dialysis and transplantation in patients with end-stage renal failure from hypernephroma. , 1986, Nephron.

[10]  S. Birkeland.  The fate of kidney-transplanted patients with a previous history of malignancy. The Scandinavian material. , 1982, Scandinavian journal of urology and nephrology.

[11]  I. Penn.  Tumors arising in organ transplant recipients. , 1978, Advances in cancer research.

[12]  F. Luft,et al.  Cisplatin pharmacokinetics in a patient with renal dysfunction. , 1978, Medical and pediatric oncology.